Regulation of IL-8 by Irsogladine maleate is involved in abolishment of Actinobacillus actinomycetemcomitans-induced reduction of gap-junctional intercellular communication
Abstract:Our previous report has shown that Irsogladine maleate (IM) counters and obviates the reduction in gap junction intercellular communication (GJIC) and the increase in IL-8 levels, respectively, induced by outer membrane protein 29 from Actinobacillus actinomycetemcomitans (A. actinomycetemcomitans) in cultured human gingival epithelial cells (HGEC). In addition, IM suppresses the increase in the secretion of IL-8 caused by whole live A. actinomycetemcomitans. These findings implicate the modulation of IL-8 lev… Show more
“…This is an important finding since GJA1 is a TSG which is associated with suppression of metastasis [30]. One explanation for GJA1 down-regulation might be strong activation of IL8 in cancerous cell lines that has been also reported previously as a suppressor of GJA1
[31]. VEGFR was over-expressed in SKBR3 and HB2.…”
BackgroundThe contribution of aberrant DNA methylation in silencing of tumor suppressor genes (TSGs) and microRNAs has been investigated. Since these epigenetic alterations are reversible, it became of interest to determine the effects of the 5-aza-2′-deoxycytidine (DAC) demethylation therapy in breast cancer at different molecular levels.Methods and FindingsHere we investigate a synoptic model to predict complete DAC treatment effects at the level of genes, microRNAs and proteins for several human breast cancer lines. The present study assessed an effective treatment dosage based on the cell viability, cytotoxicity, apoptosis and methylation assays for the investigated cell lines. A highly aggressive and a non-aggressive cell line were investigated using omics approaches such as MALDI-TOF MS, mRNA- and microRNA expression arrays, 2-D gel electrophoresis and LC-MS-MS. Complete molecular profiles including the biological interaction and possible early and late systematic stable or transient effects of the methylation inhibition were determined. Beside the activation of several epigenetically suppressed TSGs, we also showed significant dysregulation of some important oncogenes, oncomiRs and oncosuppressors miRNAs as well as drug tolerance genes/miRNAs/proteins.ConclusionsIn the present study, the results denote some new molecular DAC targets and pathways based on the chemical modification of DNA methylation in breast cancer. The outlined approach might prove to be useful as an epigenetic treatment model also for other human solid tumors in the management of cancer patients.
“…This is an important finding since GJA1 is a TSG which is associated with suppression of metastasis [30]. One explanation for GJA1 down-regulation might be strong activation of IL8 in cancerous cell lines that has been also reported previously as a suppressor of GJA1
[31]. VEGFR was over-expressed in SKBR3 and HB2.…”
BackgroundThe contribution of aberrant DNA methylation in silencing of tumor suppressor genes (TSGs) and microRNAs has been investigated. Since these epigenetic alterations are reversible, it became of interest to determine the effects of the 5-aza-2′-deoxycytidine (DAC) demethylation therapy in breast cancer at different molecular levels.Methods and FindingsHere we investigate a synoptic model to predict complete DAC treatment effects at the level of genes, microRNAs and proteins for several human breast cancer lines. The present study assessed an effective treatment dosage based on the cell viability, cytotoxicity, apoptosis and methylation assays for the investigated cell lines. A highly aggressive and a non-aggressive cell line were investigated using omics approaches such as MALDI-TOF MS, mRNA- and microRNA expression arrays, 2-D gel electrophoresis and LC-MS-MS. Complete molecular profiles including the biological interaction and possible early and late systematic stable or transient effects of the methylation inhibition were determined. Beside the activation of several epigenetically suppressed TSGs, we also showed significant dysregulation of some important oncogenes, oncomiRs and oncosuppressors miRNAs as well as drug tolerance genes/miRNAs/proteins.ConclusionsIn the present study, the results denote some new molecular DAC targets and pathways based on the chemical modification of DNA methylation in breast cancer. The outlined approach might prove to be useful as an epigenetic treatment model also for other human solid tumors in the management of cancer patients.
“…Furthermore, IM inhibits the OMP29‐induced promotion of IL‐8 expression by suppressing the phosphorylation of ERK. From the present and previous studies, IM causes the enhancement of gap junctional intercellular communication through two pathways: suppression of OMP29‐induced increase in IL‐8 through ERK and recovery of OMP29‐induced decrease in cyclic AMP levels (4,5). IM, which modulates gap junctional intercellular communication and IL‐8 expression, may be a potential therapeutic agent to prevent periodontal disease.…”
Section: Discussionmentioning
confidence: 56%
“…IM obviates the increase in IL‐8 levels and recovers the reduction of gap junctional intercellular communication in HGEC stimulated by OMP29 or A. actinomycetemcomitans (4). Furthermore, regulation of IL‐8 levels by IM causes abrogation of the reduction of gap junctional intercellular communication (5). Thus, IL‐8 is a key regulator for inflammation and the cell–cell junctional complex.…”
“…We previously reported the effectiveness of IM in HGEC following an A. actinomycetemcomitans challenge. The IM treatment had an inhibitory effect on inflammatory cytokines and on the recovery of gap junction intercellular communication in HGEC stimulated with A. actinomycetemcomitans . The increased levels of IL‐6, IL‐8, matrix metalloproteinase‐3 and intercellular adhesion molecule 1‐1 in A. actinomycetemcomitans ‐stimulated HGEC were down‐regulated with IM via the suppression of MAP kinase (p38 and ERK signaling) .…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.